MELISSA RIDELLA: Open Payments
NPI 1568006864 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,542 in 80 payments from 15 companies in 2025. Trend: 2023 $1,371 · 2024 $1,761 · 2025 $1,542
Food & beverage: $1,542
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $353 |
| ABBVIE INC. | 14 | $228 |
| Collegium Pharmaceutical, Inc. | 14 | $217 |
| Forte Bio-Pharma LLC | 10 | $211 |
| PROTEGA PHARMACEUTIALS INC | 9 | $160 |
| PFIZER INC. | 3 | $86 |
| Boston Scientific Corporation | 2 | $81 |
| SCILEX PHARMACEUTICALS INC. | 2 | $38 |
| Tonix Medicines, Inc. | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
Products named: RELISTOR, PROLATE, ROXYBOND, UBRELVY, XTAMPZA, QULIPTA, Belbuca, NURTEC ODT.
Industry payments across NV — which companies pay providers there.
